<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yoni Frista Vendarani</style></author><author><style face="normal" font="default" size="100%">Wiwin Is Effendi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Irritant-Induced Asthma: A Literature Review</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style  face="normal" font="default" size="100%">Bronchodilator</style></keyword><keyword><style  face="normal" font="default" size="100%">Health risk</style></keyword><keyword><style  face="normal" font="default" size="100%">Irritant exposure</style></keyword><keyword><style  face="normal" font="default" size="100%">Irritant-induced asthma</style></keyword><keyword><style  face="normal" font="default" size="100%">Occupational illness.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">982-988</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;One of occupational illnesses is irritant-induced asthma (IIA), which IIA is a phenotype of asthma caused by the inhalation of irritant agents. The incidence of IIA is reported as 5-18% of occupational asthma cases. In some cases, it is challenging to differentiate IIA from work-exacerbated asthma (WEA) because no specific diagnostic tests can determine whether a person has asthma caused by exposure to irritants. In any case of suspected IIA, the diagnosis of asthma should be confirmed by spirometry demonstrating airflow limitation with significant bronchodilator response or nonspecific bronchial hyperresponsiveness (NSBHR) to methacholine/histamine. IIA Management is similar to asthma management, including bronchodilator therapy and inhaled and/or systemic corticosteroids. Several studies recommend treating asthma in adults and adolescents with short-acting beta-agonists (SABA), adding a controller in the form of inhaled corticosteroids (ICS) as needed to reduce the risk of severe exacerbations and to control symptoms. This type of controller can be given regularly every day, or ICS-formoterol can be given as needed to relieve symptoms in mild asthma. Prevention that can be done at IIA includes health promotion, special protection, early diagnosis and early treatment, limitation of disabilities, and rehabilitation.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">982</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Yoni Frista Vendarani&lt;sup&gt;1&lt;/sup&gt;, Wiwin Is Effendi&lt;sup&gt;2,3*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Study Program of&amp;nbsp;Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of&amp;nbsp;Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of&amp;nbsp;Pulmonology and Respiratory Medicine, Dr. Soetomo Academic General Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pujiati Pujiati</style></author><author><style face="normal" font="default" size="100%">Soetrisno</style></author><author><style face="normal" font="default" size="100%">Dono Indarto</style></author><author><style face="normal" font="default" size="100%">Reviono</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In Vivo Studies of Combined Probiotics on IFN-γ, Ig-E and Bronchial Muscular Layer of Rats with Allergic Asthma</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style  face="normal" font="default" size="100%">Bronchus histopatology</style></keyword><keyword><style  face="normal" font="default" size="100%">IFN-γ</style></keyword><keyword><style  face="normal" font="default" size="100%">Ig-E</style></keyword><keyword><style  face="normal" font="default" size="100%">Lactobacillus brevis</style></keyword><keyword><style  face="normal" font="default" size="100%">Leuconostoc mesenteriodes</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">598-603</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;&lt;em&gt;Leuconostoc mesenteriodes&lt;/em&gt; and &lt;em&gt;Lactobacillus brevis &lt;/em&gt;are being used as probiotic to improve the immune system. The effect of probiotic containing combination of the 2 bacteria on enhancing innate and adaptive immune responses is not fully understood.&lt;strong&gt; Objective:&lt;/strong&gt; This was conducted to analyse the effect of probiotic containing in single or combination content of L. &lt;em&gt;mesenteriodes &lt;/em&gt;(Lm) and L.&lt;em&gt; brevis&lt;/em&gt; (Lb) on IFN-γ concentration, Ig-E concentration, and histopathology of bronchial muscular layer of ovalbumininduced allergic asthma. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; A total of 40 male Sprague Dawley rats (6–8 weeks, 200-300 g) were randomly divided into 5 groups: NC (non-induced control group); NgC (OVA-induced control group), Lm (OVA +probiotics containing L. &lt;em&gt;mesenteriodes&lt;/em&gt;), Lb (OVA + probiotics containing L. brevis), and Lm + Lb (OVA+probiotics containing combination of L. &lt;em&gt;mesenteriodes &lt;/em&gt;and L&lt;em&gt;. brevis&lt;/em&gt;). On 64-day, concentration of IFN-γ and Ig-E in serum were measured. Histology of bronchus was performed.&lt;strong&gt; Results: &lt;/strong&gt;IFN-γ concentration, Ig-E The administration of single or combined probiotics increased IFN-γ (p&amp;lt;0.001), yet decreased IgE (p&amp;lt;0.001) of all treatment groups, but only a combination of both probiotics reduced the thickness of the bronchial epithelium.&lt;strong&gt; Conclusion: &lt;/strong&gt;The combination of Lm and Lb single or combined probiotics improve systemic and local anti-inflammation effects and ameliorate airway remodelling in the ovalbumin-induced chronic asthma rat model.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><accession-num><style face="normal" font="default" size="100%">17</style></accession-num><section><style face="normal" font="default" size="100%">598</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Pujiati Pujiati&lt;sup&gt;1,2,*&lt;/sup&gt;, Soetrisno&lt;sup&gt;3&lt;/sup&gt;, Dono Indarto&lt;sup&gt;4&lt;/sup&gt;, Reviono&lt;sup&gt;5&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Student of Medical Sciences, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pediatrics, Kindly change to “Universitas Islam Sultan Agung, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Obstetrics and Gynecology, Universitas Sebelas Maret, Surakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Physiology, Sebelas Maret University, Surakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Pulmonogy and Respirology, Sebelas Maret University, Surakarta, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Huynh Tan Hoi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Few Potential Treatments of Asthma in Vietnam</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style  face="normal" font="default" size="100%">Health</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicine</style></keyword><keyword><style  face="normal" font="default" size="100%">Patient</style></keyword><keyword><style  face="normal" font="default" size="100%">Prevention</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">640-643</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Asthma is a chronic condition that can be fatal if it isn't treated promptly during an attack. Patients with an asthma attack cannot breathe enough air to supply the body with oxygen and within minutes, the patient can die. In Vietnam today, people can buy antibiotics on their own without the need of a doctor to prescribe or visit. Many people who only see signs of coughing, wheezing have voluntarily bought antibiotics for use. The overuse of antibiotics is very common in asthma patients. In fact, antibiotics are not effective in most types of asthma. Abuse of antibiotics is not only ineffective, but also makes the patient more tired, reduces resistance, and digestive disorders. Some antibiotics can even lead to acute asthma attacks. This article covers some of the remedies that can eradicate asthma with a combination of several fairly safe treatments. Through analysis of the scientific composition and current studies, it is possible to treat asthma and maintain good health.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">640</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Huynh Tan Hoi&amp;nbsp;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department, FPT University, VIETNAM.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noemi D. Paguigan,</style></author><author><style face="normal" font="default" size="100%">Christine L. Chichioco-Hernandez,</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">15-Lipoxygenase inhibition of selected Philippine medicinal plants</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lipoxygenase</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicinal plants</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant extracts</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">18th Feb,2014</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">6</style></volume><pages><style face="normal" font="default" size="100%">43-46</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;Several extracts from Philippine medicinal plants used for asthma and other inflammatory diseases were evaluated for their ability to inhibit the action of 15-lipoxygenase. The inhibitory activity was tested spectrophotometrically using quercetin as positive control. Eleven species belonging to 11 families displayed varying inhibitory activities. &lt;em&gt;Commelina diffusa&lt;/em&gt; and &lt;em&gt;Euphorbia hirta&lt;/em&gt; showed the highest inhibitory activity at 51.3% and 48.5%, respectively. These plants may contain new 15-lipoxygenase inhibitors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Key words: &lt;/strong&gt;Asthma, inflammation, lipoxygenase, medicinal plants, plant extra.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Noemi D. Paguigan&lt;sup&gt;1&lt;/sup&gt; and Christine L. Chichioco-Hernandez&lt;sup&gt;*,2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Natural Sciences Research Institute, University of the Philippines, Diliman, Quezon City, Philippines 1101&lt;sup&gt;&lt;/sup&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Institute of Chemistry, College of Science, University of the Philippines, Diliman, Quezon City, Philippines 1101&lt;/p&gt;</style></auth-address></record></records></xml>